Uncategorized
Humanin: The Mitochondrial Protective Peptide Research Guide
Humanin: The Mitochondrial Protective Peptide Research Guide
Humanin is a 24-amino-acid mitochondrial-derived peptide (MDP) encoded in the mitochondrial genome, first discovered in 2001 for its ability to protect neurons from Alzheimer’s disease-related insults. It has since emerged as a broad-spectrum cytoprotective peptide with effects on mitochondrial function, inflammation, metabolism, and longevity. This guide reviews its mechanism, evidence, applications, dosing, and safety.
1. What Is Humanin?
Humanin is a short mitochondrial-derived peptide encoded by the 16S rRNA region of mitochondrial DNA, translated from an alternative open reading frame. It exists in several forms, including native Humanin and analogs such as HNG (Humanin analog with enhanced potency) and AGA-(C8R)-HNG17. It acts both inside mitochondria and as a secreted signaling molecule.
- Peptide type: Mitochondrial-derived peptide (MDP)
- Encoding: Mitochondrial 16S rRNA region (alternative reading frame)
- Analogs: HNG (potency-enhanced), AGA-(C8R)-HNG17 (stabilized)
- Administration: Subcutaneous injection in research settings
- Core effects: Cytoprotection, mitochondrial function, anti-inflammation
- Status: Research compound
2. Mechanism of Action
Humanin operates through multiple cytoprotective pathways:
- Mitochondrial protection: Preserves mitochondrial membrane potential and reduces apoptosis induction
- Anti-apoptotic signaling: Interacts with the IGFBP-3 and STAT3 pathways to block cell death
- Anti-inflammatory effects: Suppresses pro-inflammatory cytokine production, including TNF-alpha
- Oxidative stress defense: Reduces reactive oxygen species and supports cellular redox balance
3. The Research Landscape
| Research area | Reported findings |
|---|---|
| Neuroprotection | Protects neurons in Alzheimer’s disease models, including against amyloid-beta toxicity |
| Cardiovascular | Improved cardiac function and reduced injury in ischemia-reperfusion models |
| Metabolic health | Improved insulin sensitivity and glucose handling in metabolic studies |
| Longevity | Declines with age; restoration studied in age-related disease models |
Humanin research is predominantly preclinical but spans a remarkably wide disease range, reflecting its role as a master cytoprotective signal.
4. Research Applications
- Neurodegeneration research: Alzheimer’s, ischemia, and mitochondrial-driven neuronal injury
- Cardiovascular research: Ischemia-reperfusion injury and cardiac aging models
- Metabolic research: Insulin resistance, glucose homeostasis, and metabolic syndrome
- Longevity research: Age-related decline and cellular stress resistance
For related mitochondrial and anti-aging peptides, see our SS-31 guide and NAD+ research guide.
5. Dosing and Protocol Notes
- Typical research dose: 2-4 mg per administration, 1-3 times per week
- Administration: Subcutaneous injection
- Reconstitution: Use bacteriostatic water; see our reconstitution and dosage guide
- Protocol duration: Research cycles commonly run 4-12 weeks
6. Side Effects and Considerations
- Injection site reactions: Local redness or discomfort
- Generally well tolerated: Limited adverse events reported in early research
- Mild systemic effects: Occasional nausea or fatigue at higher doses
- Contraindications: Pregnancy, lactation, and concurrent immunosuppressive therapy without oversight
7. Frequently Asked Questions
Is Humanin a mitochondrial antioxidant? It is a signaling peptide with antioxidant-like and anti-apoptotic effects, rather than a direct antioxidant compound.
How does Humanin relate to aging? Humanin levels decline with age in many tissues, and research explores restoration as a strategy against age-related diseases.
Can Humanin be combined with SS-31? Both target mitochondrial health through complementary mechanisms (signaling vs. cardiolipin stabilization) and are often studied together.
Related Reading
- SS-31 Mitochondrial Peptide Guide
- NAD+ Peptide and Cellular Energy Guide
- Peptides for Anti-Aging
- Peptides for Cardiovascular Health
Shop Related Research Compounds
Browse our research catalog, including Humanin, SS-31, and NAD+, all supplied with batch COAs.
Disclaimer: This article is for educational and research purposes only. Humanin is a research compound not approved for general human use. Always consult qualified professionals regarding research protocols.
